City of Hope (T Cell Manufacturing) vs ReciBioPharm: CDMO Comparison
How does City of Hope (T Cell Manufacturing) compare to ReciBioPharm for Cell & Gene Therapy manufacturing?
Side-by-side comparison of City of Hope (T Cell Manufacturing) and ReciBioPharm on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- City of Hope (T Cell Manufacturing) has more FDA inspections on record (3 vs 0) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- ReciBioPharm maintains 3 MHRA / UK GMP certificates; City of Hope (T Cell Manufacturing) does not.
- City of Hope (T Cell Manufacturing) appears as a manufacturing partner on more matched clinical programs (213 vs 0) — a broader sponsor book.
On a 13-modality CDMO landscape, both City of Hope (T Cell Manufacturing) and ReciBioPharm qualify as Cell & Gene Therapy manufacturers; ReciBioPharm carries the higher composite Signal Score for Cell & Gene Therapy programs in this comparison.
What to evaluate for Cell & Gene Therapy programs
Both City of Hope (T Cell Manufacturing) and ReciBioPharm qualify as Cell & Gene Therapy CDMOs. When choosing between them for Cell & Gene Therapy programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
Integrated vs point-solution CDMO
Ex vivo cell therapy programs benefit from CDMOs handling both vector and cell processing under one roof. Point-solution CDMOs specialize deeper but add tech-transfer complexity.
Regulatory record by process class
Cell therapy and viral vector inspections are separately scoped. Verify the CDMO's inspection record on the specific process class your program will use.
Chain-of-identity + cold chain
Autologous cell therapy demands per-patient scheduling, batch-of-one tracking, and cold-chain logistics that CDMOs vary meaningfully on. Confirm the CDMO's chain-of-identity software and cryopreservation posture.
Commercial track record
For late-stage programs, CDMOs with commercial-approved cell or gene therapy products on file carry demonstrable posture that ranking algorithms only partially capture.
Frequently asked: City of Hope (T Cell Manufacturing) vs ReciBioPharm
How does City of Hope (T Cell Manufacturing) compare to ReciBioPharm for Cell & Gene Therapy manufacturing?
On CDMO Signal's composite Signal Score, City of Hope (T Cell Manufacturing) is 84/100 and ReciBioPharm is 88/100; City of Hope (T Cell Manufacturing) has 3 FDA inspections on record vs 0 for ReciBioPharm; European coverage is 0 active EMA+MHRA certificates for City of Hope (T Cell Manufacturing) vs 3 for ReciBioPharm. Both are tracked in the CDMO Signal directory as Cell & Gene Therapy CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, City of Hope (T Cell Manufacturing) or ReciBioPharm?
Both City of Hope (T Cell Manufacturing) and ReciBioPharm maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. City of Hope (T Cell Manufacturing) has 3 FDA inspections on record; ReciBioPharm has 0.
How do City of Hope (T Cell Manufacturing) and ReciBioPharm compare on European GMP coverage?
City of Hope (T Cell Manufacturing) holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. ReciBioPharm holds 0 active EMA GMP certificates and 3 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — City of Hope (T Cell Manufacturing) or ReciBioPharm?
City of Hope (T Cell Manufacturing) is matched to 213 ClinicalTrials.gov records as a manufacturing partner; ReciBioPharm is matched to 0. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
Which is better for Cell & Gene Therapy manufacturing — City of Hope (T Cell Manufacturing) or ReciBioPharm?
Both City of Hope (T Cell Manufacturing) and ReciBioPharm are tagged as Cell & Gene Therapy CDMOs in our directory, so both are credible options for Cell & Gene Therapy programs. The most important differentiator for Cell & Gene Therapy selection is typically integrated vs point-solution cdmo: Ex vivo cell therapy programs benefit from CDMOs handling both vector and cell processing under one roof. Point-solution CDMOs specialize deeper but add tech-transfer complexity. Review each CDMO's profile and inspection record before shortlisting.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →